elocom 0,1% salve
europharma.dk aps - mometasonfuroat - salve - 0,1%
mabcampath
genzyme europe b.v. - alemtuzumab - leukæmi, lymfocytisk, kronisk, b-celle - antineoplastiske midler - mabcampath er indiceret til behandling af patienter med b-celle kronisk lymfocytisk leukæmi (bcll), for hvem fludarabinkombinationskemoterapi ikke er passende.
agonit flydende middel
hoechst schering agrevo as - linuron, orbencarb - flydende middel - 108 g/l linuron; 540 g/l orbencarb
arelon fl.e flydende middel
hoechst schering agrevo as - isoproturon - flydende middel - 500 g/l isoproturon
benasalox pulver
hoechst schering agrevo as - clopyralid, benzazol-ethyl, benazolin - pulver - 50 g/kg clopyralid ; 300 g/kg benazolin-ethyl ; (~ 269 g/kg benazolin
benasalox sc suspensionskoncentrat
hoechst schering agrevo as - clopyralid, benzazol-ethyl, benazolin - suspensionskoncentrat - 80 g/l clopyralid ; 300 g/l benazolin-ethyl ; (~ 269 g/l benazolin
betanal (gl. udgave) flydende middel
hoechst schering agrevo as - phenmedipham - flydende middel - 160 g/l phenmedipham
betanal plus flydende middel
hoechst schering agrevo as - phenmedipham - flydende middel - 160 g/l phenmedipham
betanal progress flydende middel
hoechst schering agrevo as - desmedipham, phenmedipham, ethofumesat - flydende middel - 16 g/l desmedipham ; 62 g/l phenmedipham ; 128 g/l ethofumesat
betanal progress of flydende middel
hoechst schering agrevo as - desmedipham, phenmedipham, ethofumesat - flydende middel - 20 g/l desmedipham ; 128 g/l phenmedipham ; 80 g/l ethofumesat